{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:52:01Z","timestamp":1791273121176,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.schres.2007.11.027","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T10:53:39Z","timestamp":1199703219000},"page":"252-260","source":"Crossref","is-referenced-by-count":62,"title":["Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment"],"prefix":"10.1016","volume":"100","author":[{"given":"Alasdair M.","family":"Barr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric M.","family":"Procyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2007.11.027_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/070674379704200107","article-title":"Readiness to stop smoking in schizophrenia","volume":"42","author":"Addington","year":"1997","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130050436","article-title":"Treatment of neuroleptic-induced akathisia with nicotine patches","volume":"134","author":"Anfang","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2007.11.027_bib3","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/cncr.21574","article-title":"Reduced cancer incidence among patients with schizophrenia","volume":"104","author":"Barak","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.schres.2007.11.027_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/j.1440-1614.2006.01841.x","article-title":"Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?","volume":"40","author":"Barnes","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib5","series-title":"Clinical Handbook of Psychotropic Drugs","author":"Bezchlibnyk-Butler","year":"2004"},{"key":"10.1016\/j.schres.2007.11.027_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-8993(97)00684-7","article-title":"Hippocampal cholinergic blockade enhances hypothalamic\u2013pituitary\u2013adrenal responses to stress","volume":"766","author":"Bhatnagar","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2007.11.027_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4088\/JCP.v63n0911","article-title":"The association between high nicotine dependence and severe mental illness may be consistent across countries","volume":"63","author":"de Leon","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(01)00217-1","article-title":"Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders","volume":"56","author":"de Leon","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.027_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pnpbp.2005.04.031","article-title":"Does clozapine decrease smoking?","volume":"29","author":"de Leon","year":"2005","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.schres.2006.05.009","article-title":"Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis","volume":"86","author":"de Leon","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.027_bib11","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1176\/appi.ps.53.12.1617","article-title":"Public health and therapeutic aspects of smoking bans in mental health and addiction settings","volume":"53","author":"El-Guebaly","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2007.11.027_bib12","first-page":"135","article-title":"Symptomatic hyponatremia associated with psychosis, medications, and smoking","volume":"85","author":"Ellinas","year":"1993","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.schres.2007.11.027_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2004.12.027","article-title":"Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist","volume":"57","author":"Fonder","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1744-6163.2002.tb00656.x","article-title":"Schizophrenia and the motivation for smoking","volume":"38","author":"Forchuk","year":"2002","journal-title":"Perspect. Psychiatr. Care"},{"key":"10.1016\/j.schres.2007.11.027_bib15","first-page":"344","article-title":"Effects of clozapine on smoking in chronic schizophrenic outpatients","volume":"56","author":"George","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib16","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib17","first-page":"1027","article-title":"Why patients smoke","volume":"41","author":"Glynn","year":"1990","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.149.9.1189","article-title":"Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects","volume":"149","author":"Goff","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.comppsych.2006.10.002","article-title":"Subjective effects and the main reason for smoking in outpatients with schizophrenia: a case-control study","volume":"48","author":"Gurpegui","year":"2007","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict"},{"key":"10.1016\/j.schres.2007.11.027_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.schres.2007.11.027_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psychres.2006.06.002","article-title":"Social anhedonia and schizotypy: the contribution of individual differences in affective traits, stress, and coping","volume":"149","author":"Horan","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2007.11.027_bib23","first-page":"128","article-title":"Effect of institutional smoking prohibition on Japanese inpatients with chronic schizophrenia","volume":"41","author":"Kitabayashi","year":"2006","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"10.1016\/j.schres.2007.11.027_bib24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","article-title":"Nicotine use in schizophrenia: the self medication hypotheses","volume":"29","author":"Kumari","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2007.11.027_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0893-133X(96)00018-8","article-title":"Nicotine\u2013haloperidol interactions and cognitive performance in schizophrenics","volume":"15","author":"Levin","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2007.11.027_bib26","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1176\/ps.50.10.1346","article-title":"A review of the effects of nicotine on schizophrenia and antipsychotic medications","volume":"50","author":"Lyon","year":"1999","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2007.11.027_bib27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/00004714-200012000-00023","article-title":"Mecamylamine increases cigarette smoking in psychiatric patients","volume":"20","author":"Marx","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2007.11.027_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-3223(94)00365-A","article-title":"Clozapine decreases smoking in patients with chronic schizophrenia","volume":"37","author":"McEvoy","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02246063","article-title":"Haloperidol increases smoking in patients with schizophrenia","volume":"119","author":"McEvoy","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2007.11.027_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/appi.ajp.161.1.116","article-title":"Association of anticholinergic load with impairment of complex attention and memory in schizophrenia","volume":"161","author":"Minzenberg","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib31","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4088\/JCP.v65n1217","article-title":"Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine","volume":"65","author":"Mulsant","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"28 Suppl","key":"10.1016\/j.schres.2007.11.027_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0306-4530(02)00129-4","article-title":"Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents","volume":"2","author":"Naidoo","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2007.11.027_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s002130050300","article-title":"Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers","volume":"131","author":"Peretti","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2007.11.027_bib34","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.addbeh.2007.01.013","article-title":"Motives for smoking and drinking: country and gender differences in samples of Hungarian and US high school students","volume":"32","author":"Piko","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.schres.2007.11.027_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0149-7634(84)90007-1","article-title":"Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation","volume":"8","author":"Pomerleau","year":"1984","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2007.11.027_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0899-3289(92)90014-O","article-title":"Relationship of Tridimensional Personality Questionnaire scores and smoking variables in female and male smokers","volume":"4","author":"Pomerleau","year":"1992","journal-title":"J. Subst. Abuse"},{"key":"10.1016\/j.schres.2007.11.027_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00004850-200109000-00007","article-title":"A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics","volume":"16","author":"Procyshyn","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2007.11.027_bib38","first-page":"431","article-title":"Conventional versus novel antipsychotics: changing concepts and clinical implications","volume":"24","author":"Remington","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2007.11.027_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(99)00177-2","article-title":"Neuropsychological functioning in first-episode psychosis\u2014evidence of specific deficits","volume":"43","author":"Riley","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.027_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11136-005-2808-9","article-title":"Determinants of changes in perceived quality of life in the course of schizophrenia","volume":"15","author":"Ritsner","year":"2006","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.schres.2007.11.027_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2307\/2344953","article-title":"The classification of smoking by factorial structure of motives","volume":"137","author":"Russell","year":"1974","journal-title":"J. R. Stat. Soc., A"},{"key":"10.1016\/j.schres.2007.11.027_bib42","series-title":"The Impact of Haloperidol, a Selective Dopamine D2 Antagonist, on Cognition, Motor Movements and Mood","author":"Saeedi","year":"2004"},{"key":"10.1016\/j.schres.2007.11.027_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2006.03.033","article-title":"Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood","volume":"85","author":"Saeedi","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.027_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1176\/ajp.153.4.583","article-title":"Schizophrenia, smoking, and boredom","volume":"153","author":"Smith","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0091-3057(95)02130-2","article-title":"Muscarinic antagonists are anxiogenic in rats tested in the black\u2013white box","volume":"54","author":"Smythe","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2007.11.027_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addbeh.2004.04.012","article-title":"Applicability of the Fagerstrom Test for Nicotine Dependence in smokers with schizophrenia","volume":"30","author":"Steinberg","year":"2005","journal-title":"Addict. Behav."},{"key":"10.1016\/j.schres.2007.11.027_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1360-0443.1994.tb00899.x","article-title":"Pharmacological and non-pharmacological smoking motives: a replication and extension","volume":"89","author":"Tate","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.schres.2007.11.027_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1521\/psyc.66.2.146.20623","article-title":"Boredom and psychotic disorders: cognitive and motivational issues","volume":"66","author":"Todman","year":"2003","journal-title":"Psychiatry"},{"key":"10.1016\/j.schres.2007.11.027_bib49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1440-1819.2004.01279.x","article-title":"Cigarette smoking among patients with schizophrenia and bipolar disorders","volume":"58","author":"Ucok","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2007.11.027_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-003-1648-y","article-title":"Neuroleptic dysphoria: towards a new synthesis","volume":"171","author":"Voruganti","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2007.11.027_bib51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2006.06.005","article-title":"Reliability of the Fagerstrom Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia","volume":"86","author":"Weinberger","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2007.11.027_bib52","first-page":"684","article-title":"Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia","volume":"27","author":"Yang","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2007.11.027_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0920-9964(02)00208-6","article-title":"Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia","volume":"60","author":"Yang","year":"2003","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407005397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407005397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T12:51:09Z","timestamp":1557147069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996407005397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":53,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0920996407005397"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2007.11.027","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}